IP Library Granted Patent US 7,232,886
Granted Patent B2
US 7,232,886 · App. 10/265,057 · Granted Jun 19, 2007

Method for the manufacture of recombinant unhydroxylated collagen polypeptide fibres, and recombinant unhydroxylated collagen polypeptide fibres obtained thereby

Assignee: Meristem Therapeutics
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,232,886
App. No.
10/265,057
Granted
Jun 19, 2007
Kind
B2
Abstract

The present invention relates to a process for the production of fibres of an unhydroxylated recombinant collagen polypeptide, and the fibres obtained thereby, as well as to uses of such fibres as a biomaterial.

Claims (29)

1. A method for producing an unhydroxylated recombinant collagen polypeptide fiber comprising:

a. diluting an unhydroxylated recombinant collagen polypeptide in an acid at a temperature of between about 4° C. and about 26° C.; and

b. dialyzing the diluted unhydroxylated recombinant collagen polypeptide against a buffer below the usual physiological temperature of the corresponding native collagen to form an unhydroxylated recombinant collagen polypeptide fiber.

2. The method of claim 1 , wherein the unhydroxylated recombinant collagen polypeptide is expressed by a plant.

3. The method of claim 1 , wherein the unhydroxylated recombinant collagen polypeptide expressed by a plant is obtained by insertion of one or more DNA sequences coding for said polypeptide into a plant.

4. The method of claim 1 , wherein the recombinant collagen polypeptide is a collagen comprising at least one human alpha I chain.

5. The method of claim 4 , wherein the unhydroxylated recombinant collagen polypeptide is a collagen comprising at least one human alpha I chain, and at least another human alpha chain.

6. The method of claim 4 , wherein the unhydroxylated recombinant collagen polypeptide is a collagen comprising at least three human alpha I chains.

7. The method of claim 1 , wherein the acid is 0.1M acetic acid.

8. The method of claim 1 , wherein the dialysis is carried out at 4° C.

9. The method of claim 1 , wherein the dialysis is carried out against a monopotassium phosphate buffer without the addition of salts.

10. The method of claim 9 , wherein the dialysis is carried out against a 10 mM pH 7 monopotassium phosphate buffer for 12 hours.

11. The method of claim 1 , wherein the fibers formed after dialysis are separated by centrifugation.

12. The method of claim 11 , wherein centrifugation is carried out at about 20000 G for about 10 minutes.

13. The method of claim 1 , wherein the fibers have a diameter of between about 30 nm to about 550 nm.

14. The method of claim 1 , further comprising the step of reticulating said unhydroxylated recombinant collagen fiber.

15. The method of claim 1 , further comprising the step of incorporating said unhydroxylated recombinant collagen fiber into a biomaterial.

16. The method of claim 15 , wherein said biomaterial is in the form of a sponge.

17. The method of claim 15 , wherein said biomaterial is in the form of a film or a gel.

18. The method of claim 17 , wherein said film or gel adheres to human tissue.

19. The method of claim 17 , wherein said film or gel does not adhere to human tissue.

20. The method of claim 15 , wherein said biomaterial has a three dimensional structure.

21. The method of claim 20 , wherein said three dimensional structure is the form of a tube.

22. The method of claim 15 , wherein said biomaterial is incorporated by gluing, spraying, induction, impregnation, fusion or extrusion to a prosthetic structure.

23. The method of claim 21 , wherein said prosthetic structure is a knitted web.

24. The method of claim 23 , wherein said prosthetic structure is an unknitted web.

25. The method of claim 21 , wherein said prosthetic structure is a vascular prosthesis.

26. The method of claim 23 , wherein said prosthetic structure is an endovascular prosthesis.

27. The method of claim 26 , wherein said endovascular prosthesis is a stent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2003
From: PERRET, STEPHANIE; RUGGIERO, FLORENCE
To: MERISTEM THERAPEUTICS; RUGGIERO, FLORENCE
Reel/Frame 013975/0322 →
Priority Claims (1)
FR 00 04738 · Apr 10, 2000 · national
Continuity (2)
Continuation PCTIB010056900 · Apr 9, 2001
Related Publication 20030129699A1 · Jul 10, 2003